XML 24 R10.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

REVENUES | 6 Months Ended
--- | ---
Jun. 30, 2024
REVENUES |
REVENUES | NOTE 4 – REVENUES ​ The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six Months Ended June 30, | ​ |  | ​ | Three Months Ended June 30, | ​
(U.S. dollars in thousands) |  | 2024 |  | 2023 | ​ | ​ | ​ | 2024 |  | 2023 | ​
Pfizer | ​ | $ | 8,001 | ​ | $ | 5,668 | ​ | ​ | ​ | $ | 6,874 | ​ | $ | 3,402 | ​
Brazil | ​ | $ | 7,266 | ​ | $ | 2,800 | ​ | ​ | ​ | $ | 4,716 | ​ | $ | — | ​
Chiesi | ​ | $ | 1,714 | ​ | $ | 11,673 | ​ | ​ | ​ | $ | 1,714 | ​ | $ | 11,673 | ​
Total revenues from selling goods | ​ | $ | 16,981 | ​ | $ | 20,141 | ​ | ​ | ​ | $ | 13,304 | ​ | $ | 15,075 | ​
Revenues from license and R&D services | ​ | $ | 241 | ​ | $ | 24,522 | ​ | ​ | ​ | $ | 170 | ​ | $ | 20,000 | ​
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration